电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CD70 抗体 (AA 45-193)

This 小鼠 单克隆 antibody specifically detects CD70 in WB, ELISA 和 IC. It exhibits reactivity toward 人.
产品编号 ABIN2228437
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for CD70 抗体 (AA 45-193) (ABIN2228437)

抗原

See all CD70 抗体
CD70 (CD70 Molecule (CD70))

适用

  • 126
  • 23
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1

宿主

  • 73
  • 49
  • 12
  • 5
  • 2
  • 1
  • 1
小鼠

克隆类型

  • 72
  • 70
  • 1
单克隆

标记

  • 73
  • 13
  • 12
  • 12
  • 8
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD70 antibody is un-conjugated

应用范围

  • 54
  • 52
  • 49
  • 41
  • 23
  • 19
  • 18
  • 17
  • 11
  • 9
  • 9
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA, Immunochromatography (IC)

克隆位点

7H76
  • 抗原表位

    • 9
    • 8
    • 7
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 45-193

    交叉反应

    交叉反应 (详细)

    Calculated cross reactivity: Hu

    产品特性

    CD70 (Tnfsf7, CD27 Ligand)

    纯化方法

    Purified by Protein G affinity chromatography.

    免疫原

    Recombinant protein corresponding to aa45-193 from human CD27 Ligand expressed in NS0 cells (AAA36175).

    亚型

    IgG2b
  • 应用备注

    Optimal working conditions should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Reconstitute with 200 μL sterile PBS.

    缓冲液

    Supplied as a lyophilized powder from PBS, pH 7.4, 5 % trehalose.

    储存条件

    -20 °C

    储存方法

    -20°C
  • 抗原

    CD70 (CD70 Molecule (CD70))

    别名

    CD70

    NCBI登录号

    NP_001243

    途径

    Cancer Immune Checkpoints
You are here: